Yuka Asai

Yuka Asai

Auto-generated profile, based on publicly available information

Yuka Asai

Division of Dermatology, Department of Medicine Queen's University Kingston Ontario Canada

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
SBSara J. Brown
Sara J. Brown
YAYuka Asai
Yuka Asai
HCHeather J. Cordell
Heather J. Cordell
LCLinda E. Campbell
Linda E. Campbell
YZYiwei Zhao
Yiwei Zhao
WMW. H. Irwin McLean
W. H. Irwin McLean
IgE-mediated peanut allergy is a complex trait with strong heritability, but its genetic basis is currently unknown. Loss-of-function mutations within the filaggrin gene are associated with atopic dermatitis and other atopic diseases; therefore, filaggrin is a candidate gene in the etiology of peanut allergy. To investigate the association between filaggrin loss-of-function mutations and peanut allergy. Case-control study of 71 English, Dutch, and Irish oral food challenge-positive patients with peanut allergy and 1000 non peanut-sensitized English population controls. Replication was tested in 390 white Canadian patients with peanut allergy (defined by food challenge, or clinical history and skin prick test wheal to peanut ≥ 8 mm and/or peanut-specific IgE ≥ 15 kUL(-1)) and 891 white Canadian population controls. The most prevalent filaggrin loss-of-function mutations were assayed in each population: R501X and 2282del4 in the Europeans, and R501X, 2282del4, R2447X, and S3247X in the Canadians. The Fisher exact test and logistic regression were used to test for association; covariate analysis controlled for coexistent atopic dermatitis. Filaggrin loss-of-function mutations showed a strong and significant association with peanut allergy in the food challenge-positive patients (P = 3.0 × 10(-6); odds ratio, 5.3; 95% CI, 2.8-10.2), and this association was replicated in the Canadian study (P = 5.4 × 10(-5); odds ratio, 1.9; 95% CI, 1.4-2.6). The association of filaggrin mutations with peanut allergy remains significant (P = .0008) after controlling for coexistent atopic dermatitis. Filaggrin mutations represent a significant risk factor for IgE-mediated peanut allergy, indicating a role for epithelial barrier dysfunction in the pathogenesis of this disease.

1 January 2015 in Clinical and Translational Allergy
Verified
Journal Article
Open access
PDF file
SCSabrine Cherkaoui
Sabrine Cherkaoui
MBMoshe Ben-Shoshan
Moshe Ben-Shoshan
RAReza Alizadehfar
Reza Alizadehfar
YAYuka Asai
Yuka Asai
ECEdmond Chan
Edmond Chan
ACAnn Clarke
Ann Clarke
Background: We previously estimated that the annual rate of accidental exposure to peanut in 1411 children with peanut allergy, followed for 2227 patient‐years, was 11.9% (95% CI, 10.6, 13.5). This cohort has increased to 1941 children, contributing 4589 patient‐years, and we determined the annual incidence of accidental exposure, described the severity, management, location, and identified associated factors.Findings: Children with physician‐confirmed peanut allergy were recruited from Canadian allergy clinics and allergy advocacy organizations from 2004 to May 2014. Parents completed questionnaires regarding accidental exposure to peanut over the preceding year. Five hundred and sixty‐seven accidental exposures occurred in 429 children over 4589 patient‐years, yielding an annual incidence rate of 12.4% (95% CI, 11.4, 13.4). Of 377 accidental exposures that were moderate or severe, only 109 (28.9%) sought medical attention and of these 109, only 40 (36.7%) received epinephrine. Of the 181 moderate/severe accidental exposures treated outside a health care facility, only 11.6% received epinephrine. Thirty‐seven percent of accidental exposures occurred at home. In multivariate analyses, longer disease duration, recruitment through an allergy advocacy association, and having other food allergies decreased the likelihood of accidental exposures. Age ≥ 13 years at study entry and living with a single parent increased the risk.Conclusion: Despite increased awareness, accidental exposures continue to occur, mainly at home, and most are managed inappropriately by both health care professionals and caregivers. Consequently, more education is required on the importance of strict allergen avoidance and the need for prompt and correct management of anaphylaxis.

1 July 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
YAYuka Asai
Yuka Asai
CGCelia M.T. Greenwood
Celia M.T. Greenwood
PHPeter R. Hull
Peter R. Hull
RAReza Alizadehfar
Reza Alizadehfar
MBMoshe Ben-Shoshan
Moshe Ben-Shoshan
ACAnn Clarke
Ann Clarke

26 August 2014 in International Archives of Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
YAYuka Asai
Yuka Asai
YYYarden Yanishevsky
Yarden Yanishevsky
ACAnn Clarke
Ann Clarke
SVSebastian La Vieille
Sebastian La Vieille
JDJ. Scott Delaney
J. Scott Delaney
MBMoshe Ben-Shoshan
Moshe Ben-Shoshan
Background: The Cross-Canada Anaphylaxis Registry (C-CARE) assesses the triggers and management of anaphylaxis and identifies predictors of the development of severe allergic reactions and of epinephrine use. Here, we present data from an urban adult tertiary care emergency department (ED) in Montreal, Canada. Methods: Potential anaphylaxis cases were identified using ICD-10 codes related to anaphylaxis or allergic reactions. Putative cases underwent chart review to ensure they met anaphylaxis diagnostic criteria. Demographic, clinical and management data were collected. Multivariate logistic regressions were conducted to assess the effect of demographic characteristics, triggers, and comorbidities on severity and management of reactions. Results: Among 37,730 ED visits, 0.26% (95% CI 0.21, 0.32) fulfilled the definition of anaphylaxis. Food was the suspected trigger in almost 60% of cases. Epinephrine was not administered in almost half of moderate-to-severe cases, and similar numbers of individuals with moderate-to-severe reactions were not prescribed an epinephrine autoinjector. Reaction to shellfish was associated with more severe reactions (OR 13.9; 95% CI 2.2, 89.4). Older individuals and those not receiving steroids were more likely managed without epinephrine (OR 1.04; 95% CI 1.01, 1.07 and OR 2.97; 95% CI 1.05, 8.39, respectively). Conclusions: Anaphylaxis accounted for a substantial number of ED visits in adults, and the most common trigger was food. There is non-adherence to guidelines recommending epinephrine use for all cases of anaphylaxis. We postulate that this may be related to concerns regarding the side effects of epinephrine in adults.

27 February 2013 in European Journal of Human Genetics
Verified
Journal Article
Closed access
AMAnne-Marie Madore
Anne-Marie Madore
VVVanessa T Vaillancourt
Vanessa T Vaillancourt
YAYuka Asai
Yuka Asai
RAReza Alizadehfar
Reza Alizadehfar
MBMoshe Ben-Shoshan
Moshe Ben-Shoshan
CLCatherine Laprise
Catherine Laprise

19 December 2024 in Allergy
Verified
Journal Article
Open access
AAAleix Arnau‐Soler
Aleix Arnau‐Soler
BTBénédicte L. Tremblay
Bénédicte L. Tremblay
YSYidan Sun
Yidan Sun
AMAnne‐Marie Madore
Anne‐Marie Madore
MSMathieu Simard
Mathieu Simard
YAYuka Asai
Yuka Asai
In this review, we provide an overview of food allergy genetics and epigenetics aimed at clinicians and researchers. This includes a brief review of the current understanding of genetic and epigenetic mechanisms, inheritance of food allergy, as well as a discussion of advantages and limitations of the different types of studies in genetic research. We specifically focus on the results of genome‐wide association studies in food allergy, which have identified 16 genetic variants that reach genome‐wide significance, many of which overlap with other allergic diseases, including asthma, atopic dermatitis, and allergic rhinitis. Identified genes for food allergy are mainly involved in epithelial barrier function (e.g., FLG, SERPINB7) and immune function (e.g., HLA, IL4). Epigenome‐wide significant findings at 32 loci are also summarized as well as 14 additional loci with significance at a false discovery of < 1 × 10−4. Integration of epigenetic and genetic data is discussed in the context of disease mechanisms, many of which are shared with other allergic diseases. The potential utility of genetic and epigenetic discoveries is deliberated. In the future, genetic and epigenetic markers may offer ways to predict the presence or absence of clinical IgE‐mediated food allergy among sensitized individuals, likelihood of development of natural tolerance, and response to immunotherapy.